Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenetecTSE:4492 +7.57%78 EV-to-EBITDA is 4.64 as of Aug. 31, 2026, which is 47% below its 10-year median of 8.71. GuruFocus rates TSE:4492 with a GF Score™ of 78/100 and a GF Value™ of 円771.48 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,954 Software companies, Genetec ranks better than 83.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Genetec's enterprise value is 円4,999 Mil.
Genetec's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,078 Mil. Therefore, Genetec's EV-to-EBITDA for today is 4.64.
The historical rank and industry rank for Genetec's EV-to-EBITDA or its related term are showing as below:
TSE:4492'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -11.4 Med: 8.71 Max: 57.66
Current: 4.64
During the past 9 years, the highest EV-to-EBITDA of Genetec was 57.66. The lowest was -11.40. And the median was 8.71.
TSE:4492's EV-to-EBITDA is ranked better than 83.52% of 1954
companies
in the Software industry
Industry Median: 10.54
vs TSE:4492: 4.64
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Genetec's share price for today is 円412.00.
Genetec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円42.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Genetec's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4492 vs CRM, SHOP, UBER: EV-to-EBITDA Comparison
For the Software - Application subindustry, Genetec's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetec EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Genetec's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Genetec's EV-to-EBITDA falls into.
Genetec's current Enterprise Value is 円4,999 Mil.
Genetec's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,078 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetec (TSE:4492) has a EV-to-EBITDA of 4.64 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Genetec. This is 47% below median its historical median of 8.71. According to the industry distribution chart, Genetec ranks #322 out of 1954 companies in the Software industry, placing it in the top 16.5%.
Is Genetec's EV-to-EBITDA too high?
Genetec's current EV-to-EBITDA of 4.64 is 47% below median its 10-year median of 8.71. The Software industry median EV-to-EBITDA is 10.54. Genetec's value of 4.64 is 56% below this industry median. Based on the distribution chart, Genetec ranks #322 out of 1954 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Genetec has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genetec's EV-to-EBITDA compare to CRM and SHOP?
According to the Software industry distribution chart, Genetec ranks #322 out of 1954 companies for EV-to-EBITDA. This places Genetec in the top 17% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.54. Genetec's value of 4.64 is 56% below this benchmark. While the company's 10-year median is 8.71 vs. the industry median of 10.54, Genetec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.54, based on 1,954 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genetec's current EV-to-EBITDA of 4.64 is 56% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Genetec. For the Software industry, the median EV-to-EBITDA is 10.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetec's current EV-to-EBITDA is 4.64, which is 47% below median its own 10-year median of 8.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetec stock overvalued right now?
Based on GuruFocus' analysis, Genetec (TSE:4492) is currently considered Significantly Undervalued. The stock's GF Value™ is 円771.48, compared to a current price of 円412.00 — trading 46.6% below its estimated fair value. The current EV-to-EBITDA is 4.64, which is 47% below median its 10-year median of 8.71 and 56% below the Software industry median of 10.54. Genetec's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Genetec (TSE:4492), the current EV-to-EBITDA is 4.64 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genetec (TSE:4492) Overvalued in 2026?
Based on GuruFocus' analysis, Genetec stock appears to be undervalued.
The current stock price of 円412.00 is trading 46.6% below its estimated GF Value™ of 円771.48.
GuruFocus considers Genetec to be Significantly Undervalued.
Key valuation signals for TSE:4492:
EV-to-EBITDA: 4.64 (47% below median its 10-year median of 8.71)
GF Value™: 円771.48 vs. price of 円412.00 (46.6% below fair value)
Industry Position: 56% below the Software median (#322 of 1954)
No single metric tells the full story. See the TSE:4492 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genetec Corp is engaged in the provision of system development, engineering, and IOT/cloud solutions. Its services include software development, hardware development, engineering solutions, Mastercam, Robomaster, flexisim, IoT/M2M business, surve-I, Coco Dayo, and web integration.
78GF Score
Get the complete analysis for TSE:4492
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4492 has been successfully added to your 
